290 related articles for article (PubMed ID: 1727711)
1. Pancreatic islet ganglioside expression in nonobese diabetic mice: comparison with C57BL/10 mice and changes after autoimmune beta-cell destruction.
Dotta F; Peterson LB; Previti M; Metzger J; Tiberti C; Anastasi E; Zoppitelli P; Wicker LS; Di Mario U
Endocrinology; 1992 Jan; 130(1):37-42. PubMed ID: 1727711
[TBL] [Abstract][Full Text] [Related]
2. Rat pancreatic ganglioside expression: differences between a model of autoimmune islet B cell destruction and a normal strain.
Dotta F; Tiberti C; Previti M; Anastasi E; Andreani D; Lenti L; Pontieri GM; Gianani R; Appel MC; Eisenbarth GS
Clin Immunol Immunopathol; 1993 Feb; 66(2):143-9. PubMed ID: 8453786
[TBL] [Abstract][Full Text] [Related]
3. Ganglioside expression in human pancreatic islets.
Dotta F; Colman PG; Lombardi D; Scharp DW; Andreani D; Pontieri GM; Di Mario U; Lenti L; Eisenbarth GS; Nayak RC
Diabetes; 1989 Nov; 38(11):1478-83. PubMed ID: 2695376
[TBL] [Abstract][Full Text] [Related]
4. The GM2-1 ganglioside islet autoantigen in insulin-dependent diabetes mellitus is expressed in secretory granules and is not beta-cell specific.
Dotta F; Previti M; Neerman-Arbez M; Dionisi S; Cucinotta D; Lenti L; Di Mario U; Halban PA
Endocrinology; 1998 Jan; 139(1):316-9. PubMed ID: 9421429
[TBL] [Abstract][Full Text] [Related]
5. Autoimmunity to the GM2-1 islet ganglioside before and at the onset of type I diabetes.
Dotta F; Gianani R; Previti M; Lenti L; Dionisi S; D'Erme M; Eisenbarth GS; Di Mario U
Diabetes; 1996 Sep; 45(9):1193-6. PubMed ID: 8772721
[TBL] [Abstract][Full Text] [Related]
6. Target antigens in autoimmune diabetes: pancreatic gangliosides.
Dionisi S; Dotta F; Diaz-Horta O; Carabba B; Viglietta V; Di Mario U
Ann Ist Super Sanita; 1997; 33(3):433-5. PubMed ID: 9542277
[TBL] [Abstract][Full Text] [Related]
7. Gangliosides and autoimmune diabetes.
Misasi R; Dionisi S; Farilla L; Carabba B; Lenti L; Di Mario U; Dotta F
Diabetes Metab Rev; 1997 Sep; 13(3):163-79. PubMed ID: 9307889
[TBL] [Abstract][Full Text] [Related]
8. A distinct ganglioside composition of rat pancreatic islets.
Saito M; Sugiyama K
Arch Biochem Biophys; 2000 Apr; 376(2):371-6. PubMed ID: 10775425
[TBL] [Abstract][Full Text] [Related]
9. IFN-gamma gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice.
Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Bleackley RC; Power RF
J Immunol; 1995 May; 154(9):4874-82. PubMed ID: 7722337
[TBL] [Abstract][Full Text] [Related]
10. Specific destruction of islet transplants in NOD<-->C57BL/6 and NOD<-->C3H/Tif embryo aggregation chimeras irrespective of allelic differences in beta-cell antigens.
Leijon K; Hillörn V; Bergqvist I; Holmberg D
J Autoimmun; 1995 Jun; 8(3):347-56. PubMed ID: 7575996
[TBL] [Abstract][Full Text] [Related]
11. Inducible nitric oxide synthase (iNOS) in pancreatic islets of nonobese diabetic mice: identification of iNOS- expressing cells and relationships to cytokines expressed in the islets.
Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Bleackley RC
Endocrinology; 1996 May; 137(5):2093-9. PubMed ID: 8612552
[TBL] [Abstract][Full Text] [Related]
12. Effect of H-2 compatibility in autoimmune destruction of islet allografts from B10 congenic lines to nonobese diabetic mice.
Clare-Salzler M; Mullen Y; Chai A; Stein E; Girman D; Lennartz K
Pancreas; 1994 Mar; 9(2):179-85. PubMed ID: 8190719
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic islet blood perfusion in the nonobese diabetic mouse: diabetes-prone female mice exhibit a higher blood flow compared with male mice in the prediabetic phase.
Carlsson PO; Sandler S; Jansson L
Endocrinology; 1998 Aug; 139(8):3534-41. PubMed ID: 9681505
[TBL] [Abstract][Full Text] [Related]
14. Evidence that beta cell death in the nonobese diabetic mouse is Fas independent.
Thomas HE; Darwiche R; Corbett JA; Kay TW
J Immunol; 1999 Aug; 163(3):1562-9. PubMed ID: 10415060
[TBL] [Abstract][Full Text] [Related]
15. [Studies on the pathogenesis of type I diabetes mellitus--destruction of pancreatic beta cells by cytotoxic T lymphocytes in nonobese diabetic mice].
Nagata M
Nihon Naibunpi Gakkai Zasshi; 1990 Mar; 66(3):145-58. PubMed ID: 2189754
[TBL] [Abstract][Full Text] [Related]
16. Beta-cell markers and autoantigen expression by a human insulinoma cell line: similarities to native beta cells.
Cavallo MG; Dotta F; Monetini L; Dionisi S; Previti M; Valente L; Toto A; Di Mario U; Pozzilli P
J Endocrinol; 1996 Jul; 150(1):113-20. PubMed ID: 8708552
[TBL] [Abstract][Full Text] [Related]
17. Gene transfection and expression of transforming growth factor-beta1 in nonobese diabetic mouse islets protects beta-cells in syngeneic islet grafts from autoimmune destruction.
Suarez-Pinzon WL; Marcoux Y; Ghahary A; Rabinovitch A
Cell Transplant; 2002; 11(6):519-28. PubMed ID: 12428741
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
Gallichan WS; Balasa B; Davies JD; Sarvetnick N
J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
[TBL] [Abstract][Full Text] [Related]
19. Destruction of pancreatic islet cells by cytotoxic T lymphocytes in nonobese diabetic mice.
Nagata M; Yokono K; Hayakawa M; Kawase Y; Hatamori N; Ogawa W; Yonezawa K; Shii K; Baba S
J Immunol; 1989 Aug; 143(4):1155-62. PubMed ID: 2663991
[TBL] [Abstract][Full Text] [Related]
20. Oral administration of insulin to female nonobese diabetic mice inhibited diabetes and induced Fas ligand expression on islets of Langerhans.
Wang H; Li Y; Sun Q; Yang G
Chin Med J (Engl); 2000 May; 113(5):433-6. PubMed ID: 11776099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
